Your Javascript appears to be disabled. In order to experience Universe, you need to turn your Javascript on.

The Cannabis Society Business Conference NYC (Invite Only)

One Penn Plaza Suite 4430 New York, NY 10119

New York, NY, USA New York

40.7127753 -74.0059728

Description

The Cannabis Society is dedicated to fostering the cannabis community through events, conferences, dinners, & many more. Join us together with Industry experts, entrepreneurs, investors and service providers for Cannabis Business Conference on Tuesday, February 19th in New York City. Tentative Schedule (subject to change) 5:30 PM: Registration and Deal Making5:45 PM: Opening Remarks by The Cannabis Society6:00 PM: Keynote by Tom Zuber Managing Partner of Zuber Lawler & Del Duca LLP.6:20 PM: Keynote by WVC Holdings's Paul Hennessy, Senior VP Sales of Contract Pharmacal Corp6:40 PM: Investments in Cannabis Panel w/ Zuber Law, Art Assets, Welcan Capital & Phyto Partners 7:05 PM: WVC Holdings' CBD & Hemp Panel7:35 PM: Product Innovation Panel with Etain Health, Urbania Investment Group, Cherry LLC and NACB8:00 PM: Deal Making9:00 PM: Conference Conclusion Confirmed Guest Speakers: Tom Zuber, Managing Partner of Zuber Lawler & Del Duca LLP. Tom Zuber has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. Tom holds a law degree from Columbia Law School, a master’s degree in public policy from Harvard Government School, and a biomedical engineering degree from Rutgers University, where he graduated with highest honors. Eugene Morgulis, Director of Legal & Strategic Initiatives, National Association of Cannabis Businesses As the NACB’s LA-based executive and Director of Legal & Strategic Initiatives, Eugene Morgulis oversees the creation of the organization’s National Standards and heads up its Symposium program. Eugene's legal career began at the international law firm Ropes & Gray in Boston, MA. His practice included Regulatory, Cybersecurity and Data Privacy law. In 2013, he was awarded the Lawyers’ Committee for Civil Rights and Economic Justice Recognition Award for his work on NAACP v. Galvin, which expanded access to voter registration for low-income Massachusetts citizens. More information about the NACB can be found at NACB.com. Matt Wolf, CEO, WVC Holdings, Inc. & CEO, Contract Pharmacal Corp Matt is the CEO of Contract Pharmacal Corp. (“CPC”), a contract development and manufacturing organization focused on OTC and Rx drug products as well as nutraceuticals. Matt has been with CPC for over 20 years, and has grown the business from $15 million in 1997 to $180 million in 2018. CPC's manufacturing operations span more than 625,000 square feet across several facilities with the capacity to produce more than 17 billion capsules, tablets and other solid dose formats annually, with the ability to fill more than 120 million bottles per year. CPC maintains strong relationships with hundreds of customers globally and has commercialized more than five thousand products worldwide. Matt has been instrumental in establishing a company mission and culture that is focused on quality, efficiency, and service. In early 2016, Matt recognized the opportunity within the cannabis industry and moved to Colorado to get involved. Since then, Matt has assembled a team with deep investment, operating, marketing and scientific expertise to form WVC Holdings, Inc. ("WVCH"). WVCH is now building a synergistic portfolio of distinct businesses to capitalize on the opportunities presented in the industry. WVCH's current investments include: Uleva, a hemp supplement targeted at the mass market; Ascent Naturals, a botanical extraction operation including hemp; Cultivarian, a line of THC products for legal states; and Kindred Wolf, a full service marketing agency serving the industry. WVCH strives to capitalize on the team’s decades of experience to positively affect an energized industry and deliver products that will make a difference in peoples’ lives. Barbara (Bobbi) Koz Paley, Art Assets LLC Founder and CEO Bobbi Koz Paley is a ChangeMaker with a proven track record of identifying cultural shifts, investing early, and creating connections across multiple industries and sectors. She has been on the cusp of myriad cultural trends in her lifetime, establishing herself as an early player in real estate, art, and cannabis before they were asset classes. A pioneer in Design Thinking, she has consistently embraced innovation and opportunity to create value. In 2014, anticipating the looming cultural, economic, and technological transformations in the cannabis industry, Bobbi partnered with her son, Jamie Koz. Uniting her creativity with his decades of experience in cannabis cultivation, they originally opened four micro-grows in Los Angeles, joined ArcView’s global network of leading investors and entrepreneurs, and established an evolving ecosystem among their investments, makers, and fellow investors. Barry Bordetsky, Cherry LLC Chief Legal Advisor Barry comes into the cannabis field with a litigation background, representing individuals, publicly and privately held entities, brokerage firms and registered representatives in state and federal courts, as well as arbitration forums, throughout the country. Barry's extensive litigation and securities experience provides Cherry with yet another diversified outlook, in this instance as an attorney who knows how to limit potential exposure to clients and protect the clients’ interests should a matter formalize. Barry combines his experience as a commercial and securities litigator with his background as a former general counsel of a publicly traded company to provide Cherry with an understanding and preparation for legal obstacles that are before the industry now, and may be presented in the future. Marty Ford, President of Ascent Naturals With degrees in engineering and business administration, Marty Ford’s career as an operations leader has been spent turning underperforming companies into peak performers. His experience has been focused in the medical device and nutraceutical manufacturing industries with an added stint as VP of Operations at the largest manufacturer and wholesaler of high-end kayaks in the world. Paul Hennessy, Senior VP Sales of Contract Pharmacal Corp With a legacy of experience gained while working for many world renown healthcare brands, Paul helps lead the strategic direction and business integration of CPC and our many partners. A well-rounded professional, when he isn’t negotiating a deal, Paul can be found lending his engineering background to our packaging team. Vikas Desai, Founding Partner at WelCan Capital Vikas Desai is a founder and partner at WelCan Capital, a venture capital firm focused in the cannabis industry. WelCan invests in high-impact, foundational companies across early-stage plant touching and ancillary businesses. With an emphasis on seed investing, WelCan looks to align with experienced entrepreneurs solving key problems that exist in the industry. Prior to WelCan, Vikas was a private equity investor at Oaktree Capital Management and began his career at Morgan Stanley in investment banking, focusing on real estate M&A and capital markets. Evan Schnurmacher, Junior analyst at Phyto Partners Evan Schnurmacher began his professional career in the film industry. Evan held several positions at companies including Information Television and The Birds Nest Foundation. For the past 2 years Evan has held sales and client delivery roles at Yext. At the start of 2019, Evan joined Phyto Partners as an Junior analyst. His roles include dealflow intake, researching investment targets and attending industry conferences to establish a presence and network in the industry. Evan graduated University of Maryland with a BA. Sam Potter, President of WVC Holdings, Inc. Sam Potter is a graduate of the Kelley School of Business with 11+ years in investment banking, principal investing and working with early-stage companies. He has also served as VP of Finance for a Colorado-based start-up company. Amy K. Peckham, CEO and co-founder of Etain, LLC Amy K. Peckham co-founded Etain, LLC with her daughters Hillary and Keeley. They have established New York's Only Women-Owned Medical Marijuana Business. Etain is a family-run business committed to manufacturing clean, safe, and consistent medical marijuana products for the patients of New York State. Etain, LLC is one of the first five vertically integrated registered organizations providing medical marijuana products under the New York Compassionate Care Act enacted July, 2014 by Governor Andrew M. Cuomo. Current retail locations: NYC, Yonkers, Kingston & Syracuse. Etain is currently expanding operations into California. Rich Roginsky, VP Operation of Kindred Wolf Rich has shot on 6 of 7 continents, but is still holding out for Antarctica. From corporate giants, to pharmaceutical brands involved with some of the rarest diseases, his production skill is matched only by his contagious personality that clients, crew, talent, and patients adore. Derek Pellizzari - CEO and Director for Urbania Investment Group With over 26 years of experience specializing in business development, Derek has a successful track record leading both mid and large size companies to achieve their revenue goals through effective cost management, marketing and sales. He was vice president of Golden Eagle Group, one of the largest agricultural corporations in Canada, as well a division of the Aquilini Investment Group. Vice President of Sale and Marketing at Rubicon Organics, a publicly traded licenced producer of cannabis since 2015 in Washington, California and Canada. Derek is currently a partner and managing director at Kika Marketing and Communications Inc, a full-service marketing, design and web agency with an international reach and offices in Vancouver, Montreal and Manila. Nick Kingsbury, Regulatory Compliance Director of Kindred Wolf Nick is a licensed New York attorney specializing in regulatory and compliance. He provides an extra layer of security for ensuring our clients’ messaging stays on point and above board. Gold Sponsor Community Partner

This listing has no upcoming events

Start: 2019-02-19T17:00:00-05:00

End: 2019-02-19T21:00:00-05:00

Tickets

Early Bird 49.0 USD 20

General Admission 69.0 USD 50